Your Pharmaceutical Consultant

Strategy and Development

Strategy and Pharmaceutical Development

PDG provides pharmaceutical strategy and development consulting expertise and serves as our clients’ regulatory voice at FDA. Whether you require a 505(b)(1) or 505(b)(2) NDA, PDG employs pharmaceutical industry professionals who routinely and successfully present client-proposed regulatory strategies to the Agency.
Continue reading

Pre-IND Meetings

New Drug Meetings

PDG’s team of industry professionals has extensive experience in planning Pre-IND Meetings on our clients’ behalf (as well as other Type B Meetings). Continue reading